ACXP
Acurx Pharmaceuticals LLC
NASDAQ: ACXP · HEALTHCARE · BIOTECHNOLOGY
$2.16
+0.00% today
Updated 2026-05-01
Market cap
$5.62M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-5.32
Dividend yield
—
52W range
$1 – $21
Volume
3.8M
Acurx Pharmaceuticals LLC (ACXP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.99M | $-3.35M | $-5.01M | $-7.54M | $-9.80M | $-10.38M | $-6.79B |
| Capital expenditures | $0.00 | $0.00 | $3.00 | $0.00 | $5.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $900431.00 | $1.27M | $6.74M | $3.30M | $3.77M | $3.44M | $1.25B |
| Free cash flow | $-3.99M | $-3.35M | $-5.01M | $-7.54M | $-9.80M | $-10.38M | $-6.79B |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |